Stay updated on Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial
Sign up to get notified when there's something new on the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page.

Latest updates to the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.5.2 is now listed, replacing the previous Revision: v3.5.0.SummaryDifference0.1%

- Check8 days agoChange DetectedA new version entry was added to the Record History, reflecting updates to the study record such as status, design, eligibility, and contacts/locations.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedRevision history shows the addition of v3.5.0 and the removal of v3.4.3.SummaryDifference0.1%

- Check37 days agoChange DetectedRecord History shows the addition of Revision: v3.4.3 and the deletion of Revision: v3.4.2.SummaryDifference0.1%

- Check65 days agoChange DetectedAdded Revision: v3.4.2 and removed the funding-notice block along with the prior Revision: v3.4.1 entry.SummaryDifference0.8%

- Check72 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status, and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

Stay in the know with updates to Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page.